| Project/Area Number |
08672462
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Chemical pharmacy
|
|---|
| Research Institution | Osaka University of Pharmaceutical Sciences |
|---|
Principal Investigator |
KURIHARA Takushi Osaka University of Pharmaceutical Sciencies, Professor, 薬学部, 教授 (90067281)
|
|---|
| Project Period (FY) |
1996 – 1998
|
| Project Status |
Completed (Fiscal Year 1998)
|
| Budget Amount *help |
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1996: ¥900,000 (Direct Cost: ¥900,000)
|
|---|
| Keywords | histamine / H_3 / receptor / agonist / antagonist / imidazole / C-nucleoside / conformation / ヒスタミンH_2拮抗薬 / イミダゾールC-ヌクレオシド / 消化性潰瘍治療薬 / シメチジン / 光延反応 |
|---|
| Research Abstract |
We recently reported the beta-stereoselective synthesis of C-4 linked imidazole nucleosides, On the basis of what we have now, we became interested in the synthesis of the four possible stereoisomerers of a novel imidazole C-nucleoside (ICN) analogues in which the imidazole and amino groups were restricted across a tetrahydrofuran ring. A synthetic route to the four possible stereoisomers of a novel 2' 3' dideoxyimidazole C-nucleoside derivative was at first developed via the efficient use of PhSe group from L-glutamic acid. The key intermediates selenolactols were successively derived to the respective 5 arnino-2', 3' -dideoxy-ICN derivatives in excellent yields Their enantiomers were provided via nucleosides from D-glutarnic acid by the same methodology. The four isomers of 5' Amino-2', 3' didehydro-2' 3' dideoxy-ICN were also synthesized via oxidative elimination the C2'-phenylselenyl group of the intermediates. Further, 4(5)-(5-aminomethylfuran-2-yl)-1H-imidazole (5) was synthesized starting from D-ribose. Of particular interest, only (+)-4(5)-{(2R,5R)-5-(aminomethyl)-tetrahydrofuran-2-yl}imidazole named imifuramine, was identified as a H_3 agonist by in vivo brain microdialysis.
|
